DRUGS Act

S 4108 (the DRUGS Act) requires domain name registrars and registry operators to lock and suspend internet domains used for illegal online drug sales within 24 and 7 days, respectively, after receiving a verified report from authorized agencies like the FDA, DEA, or state pharmacy boards. It directly affects domain registrars (e.g., GoDaddy, Namecheap) and websites facilitating illegal drug transactions. Key provisions include strict timelines for action, mandatory evidence submission by reporters, and an appeal process where registrants can contest suspensions by providing valid pharmacy licenses. The bill targets the infrastructure of illegal online drug sales without altering drug laws or directly penalizing sellers.